ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.746,18
0,39%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Odonate Therapeutics Inc (ODT)

  7. Odonate Therapeutics Inc (ODT) News

ODT

Odonate Therapeutics (ODT)

Odonate Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ODT
DatumZeitQuelleÜberschriftSymbolFirma
10/02/202218h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ODTOdonate Therapeutics Inc
07/02/202215h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ODTOdonate Therapeutics Inc
31/01/202212h14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ODTOdonate Therapeutics Inc
31/01/202212h14Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ODTOdonate Therapeutics Inc
31/01/202212h11Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202215h01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202215h01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202215h00Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202215h00Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ODTOdonate Therapeutics Inc
26/01/202215h00Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ODTOdonate Therapeutics Inc
25/01/202223h31Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202215h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
07/01/202215h00Business WireOdonate Announces Expected Delisting of Its StockNASDAQ:ODTOdonate Therapeutics Inc
11/12/202100h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ODTOdonate Therapeutics Inc
10/12/202123h24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ODTOdonate Therapeutics Inc
25/11/202100h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ODTOdonate Therapeutics Inc
22/11/202117h09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ODTOdonate Therapeutics Inc
19/11/202123h08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ODTOdonate Therapeutics Inc
18/11/202123h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
18/11/202119h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ODTOdonate Therapeutics Inc
17/11/202113h45Business WireOdonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase PlanNASDAQ:ODTOdonate Therapeutics Inc
10/11/202123h15Business WireOdonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
10/11/202123h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ODTOdonate Therapeutics Inc
08/09/202113h00GlobeNewswire Inc.SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the FirmNASDAQ:ODTOdonate Therapeutics Inc
05/08/202122h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
27/07/202114h30Business WireOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021NASDAQ:ODTOdonate Therapeutics Inc
27/07/202114h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ODTOdonate Therapeutics Inc
02/07/202122h07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ODTOdonate Therapeutics Inc
25/06/202122h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ODTOdonate Therapeutics Inc
01/06/202122h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ODTOdonate Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ODT

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
TG
D7G
Nel ASA
FX
EURJPY
Euro vs Yen
TG
DTE
Deutsche Telekom
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
DBI
TDXP
Tec DAX
AMEX
SPY
SPDR S&P 500
NYSE
KO
Coca Cola
DBI
MDAX
MDAX
TG
CBK
Commerzbank
TG
ALV
Allianz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten